SLAP deficiency enhances number and function of regulatory T cells preventing chronic autoimmune arthritis in SKG mice.
To test if manipulating TCR complex-mediated signaling (TCR signaling) could treat autoimmune disease, we generated the double SKG Src-like adapter protein (SLAP) knockout (DSSKO) mouse model. The SKG mutation in ZAP70 and SLAP have opposing functions on the regulation of TCR signaling. The combination of these two mutations alters TCR signaling in the context of a defined genetic background, uniform environmental conditions, and a well-characterized signaling disruption. In contrast to SKG mice, DSSKO mice do not develop zymosan-induced chronic autoimmune arthritis. This arthritis prevention is not due to significant alterations in thymocyte development or repertoire selection but instead enhanced numbers of regulatory T cells (Tregs) and decreased numbers of Th17 cells skewing the ratio of Tregs to autoreactive effector T cells. Treg depletion and/or functional blockade led to the development of arthritis in DSSKO mice. In vitro suppression of effector T cell proliferation was also enhanced, demonstrating that DSSKO mice have increased numbers of Tregs with increased function. Understanding how TCR signals influence development, expansion, and function of Tregs in DSSKO mice could advance our ability to manipulate Treg biology to treat ultimately autoimmune disease.
Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA.
Lisa K
LK
Peterson
Laura A
LA
Shaw
Anthony
A
Joetham
Shimon
S
Sakaguchi
Erwin W
EW
Gelfand
Leonard L
LL
Dragone
D000818:Animals; D001169:Arthritis, Experimental / Q000235:genetics / Q000276:immunology / Q000517:prevention & control*; D001327:Autoimmune Diseases / Q000235:genetics / Q000276:immunology / Q000517:prevention & control*; D002908:Chronic Disease; D004195:Disease Models, Animal; D018655:Lymphocyte Count; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D008822:Mice, Transgenic; D016392:Proto-Oncogene Proteins pp60(c-src) / Q000172:deficiency* / Q000235:genetics; D050378:T-Lymphocytes, Regulatory / Q000276:immunology* / Q000473:pathology*; D015854:Up-Regulation / Q000235:genetics* / Q000276:immunology*; D051746:ZAP-70 Protein-Tyrosine Kinase / Q000235:genetics
C095148:Sla protein, mouse; D016392:Proto-Oncogene Proteins pp60(c-src); D051746:ZAP-70 Protein-Tyrosine Kinase; C497262:Zap70 protein, mouse
Nat Rev Immunol. 2008 Jul;8(7):545-58
18551129
Immunity. 2001 Sep;15(3):457-66
11567635
Immunity. 2007 Dec;27(6):912-26
18093540
Nat Protoc. 2007;2(7):1789-94
17641646
J Exp Med. 2009 Oct 26;206(11):2527-41
19841086
Nat Immunol. 2001 Apr;2(4):301-6
11276200
Immunity. 2009 May;30(5):616-25
19464984
J Immunol. 2002 May 1;168(9):4399-405
11970982
Cell. 2008 Mar 7;132(5):846-59
18329370
PLoS One. 2010 May 10;5(5):e10558
20479941
J Exp Med. 2003 Jul 21;198(2):249-58
12874258
Cell. 1992 Nov 13;71(4):649-62
1423621
J Immunol. 2010 Aug 15;185(4):2295-305
20644168
J Exp Med. 2007 Jan 22;204(1):41-7
17227914
Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5919-24
20231436
J Immunol. 2000 Jan 1;164(1):183-90
10605010
Arthritis Res Ther. 2009;11(1):202
19232064
Nature. 2003 Nov 27;426(6965):454-60
14647385
J Exp Med. 2008 Sep 1;205(9):1983-91
18725525
J Cell Biol. 2005 Jul 18;170(2):285-94
16027224
Arthritis Res Ther. 2005;7(2):R402-15
15743488
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18202-7
17110436
J Exp Med. 2010 Aug 30;207(9):1871-8
20679400
J Exp Med. 2010 Aug 30;207(9):1819-23
20805565
J Immunol. 2007 Apr 1;178(7):4136-46
17371969
J Exp Med. 2005 Mar 21;201(6):949-60
15781585
Nat Immunol. 2006 Jan;7(1):57-66
16327786
J Immunol. 2006 Jan 1;176(1):335-45
16365426
J Immunol. 2002 Jun 15;168(12):5979-83
12055202